Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9097 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8732 |
High Similarity |
NPD1510 |
Phase 2 |
0.8707 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8681 |
High Similarity |
NPD1549 |
Phase 2 |
0.8671 |
High Similarity |
NPD2796 |
Approved |
0.8621 |
High Similarity |
NPD2800 |
Approved |
0.8611 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8611 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8582 |
High Similarity |
NPD1240 |
Approved |
0.8571 |
High Similarity |
NPD7075 |
Discontinued |
0.8523 |
High Similarity |
NPD1512 |
Approved |
0.8497 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8462 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8435 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8421 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8389 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8389 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8323 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8312 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8301 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8299 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8269 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8258 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8258 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8258 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8247 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8217 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8188 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8163 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8163 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8121 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8098 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8089 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8067 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8038 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8025 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8025 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7987 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7987 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7931 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7914 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7844 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.784 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7818 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7798 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7784 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7771 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7756 |
Intermediate Similarity |
NPD920 |
Approved |
0.775 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7746 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7742 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7742 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7742 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7733 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7725 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7712 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7708 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7702 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7682 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7679 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7676 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7655 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7651 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7636 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7628 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD919 |
Approved |
0.7588 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD943 |
Approved |
0.7576 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7568 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7561 |
Intermediate Similarity |
NPD5494 |
Approved |
0.756 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7547 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7532 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7515 |
Intermediate Similarity |
NPD1247 |
Approved |
0.75 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7471 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7466 |
Intermediate Similarity |
NPD2797 |
Approved |
0.745 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7432 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7431 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7427 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7427 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7423 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7394 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7386 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7379 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7374 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7342 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD411 |
Approved |
0.7333 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7314 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7303 |
Intermediate Similarity |
NPD447 |
Suspended |
0.729 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.729 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7286 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7273 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7254 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7251 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7237 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD3267 |
Approved |
0.723 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7222 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7205 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7193 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7188 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7167 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7167 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.716 |
Intermediate Similarity |
NPD5710 |
Approved |
0.716 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7133 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7127 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7127 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD1470 |
Approved |
0.711 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7105 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7086 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7078 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7067 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7048 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7044 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7039 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7039 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7039 |
Intermediate Similarity |
NPD7095 |
Approved |
0.703 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.7014 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6982 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.6973 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD2353 |
Approved |
0.6962 |
Remote Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD1201 |
Approved |
0.6939 |
Remote Similarity |
NPD17 |
Approved |
0.6939 |
Remote Similarity |
NPD1778 |
Approved |
0.6933 |
Remote Similarity |
NPD5049 |
Phase 3 |
0.6933 |
Remote Similarity |
NPD1876 |
Approved |
0.6933 |
Remote Similarity |
NPD8651 |
Approved |
0.6931 |
Remote Similarity |
NPD7584 |
Approved |
0.6919 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6903 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6903 |
Remote Similarity |
NPD3140 |
Approved |
0.6903 |
Remote Similarity |
NPD3142 |
Approved |
0.6903 |
Remote Similarity |
NPD1613 |
Approved |
0.6899 |
Remote Similarity |
NPD5406 |
Approved |
0.6899 |
Remote Similarity |
NPD5404 |
Approved |
0.6899 |
Remote Similarity |
NPD5405 |
Approved |
0.6899 |
Remote Similarity |
NPD5408 |
Approved |
0.6897 |
Remote Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6894 |
Remote Similarity |
NPD3887 |
Approved |
0.6887 |
Remote Similarity |
NPD1164 |
Approved |
0.6886 |
Remote Similarity |
NPD6279 |
Approved |
0.6886 |
Remote Similarity |
NPD6280 |
Approved |
0.6875 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6871 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6867 |
Remote Similarity |
NPD6585 |
Discontinued |
0.686 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.686 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6855 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6829
|
Remote Similarity |
NPD6273 |
Approved |